Webinar to take place on Monday, June 5, 2023 at 12:30 PM ETNEW YORK, May 25, 2023) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes
There are no effective treatments for intracerebral hemorrhage (ICH), which has a 30% to 40% mortality rateIntranasal anti-CD3 mAb treatment showed a reduction in Intracerebral Hemorrhage injury severityIntranasal
Tiziana Life Sciences Announces Findings from Intranasal Anti-CD3 mAb Treatment in Intracerebral Hemorrhage at the Annual American Academy of Neurology ConferenceThere are no effective treatments for intracerebral hemorrhage (ICH), which has a 30% to 40% mortality rateIntranasal anti-CD3 mAb treatment showed a reduc.
Tiziana Life Sciences (TLSA) Announces Findings from Intranasal Anti-CD3 mAb Treatment streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.